Results from animal studies and preliminary data from pilot studies in patients with primary biliary cirrhosis suggest that tauro-ursodeoxycholic acid has metabolic properties that may favour its long-term use as an alternative to ursodeoxycholic acid for patients with chronic cholestatic liver diseases. No direct comparison of tauro-ursodeoxycholic and ursodeoxycholic acids have yet been carried out in primary biliary cirrhosis.
|Titolo:||Ursodeoxycholic and tauro-ursodeoxycholic acids for the treatment of primary biliary cirrhosis: a pilot crossover study|
|Parole Chiave:||Taurochenodeoxycholic Acid; Lipids; Humans; Cholagogues and Choleretics; Liver; Cross-Over Studies; Pilot Projects; Middle Aged; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid|
|Settore Scientifico Disciplinare:||Settore MED/09 - Medicina Interna|
|Data di pubblicazione:||apr-1997|
|Digital Object Identifier (DOI):||10.1046/j.1365-2036.1997.124295000.x|
|Appare nelle tipologie:||01 - Articolo su periodico|